Rob ten Hoedt

Chairman and Member of the Operations Management Committee

Rob ten Hoedt is Executive Vice President & President, Europe, Middle East & Africa (EMEA) and a member of Medtronic’s Executive Committee.  Mr. ten Hoedt has been with Medtronic since 1991 and has over 25 years of experience in the medical device industry. Prior to Medtronic, he has held positions in medical technology companies such as Arjo Hospital Equipment and Polystan Benelux and also ran his own Distributor Company for several years.  Rob holds a degree in Commercial Economy from the H.E.A.O. and a Masters in Marketing from the NIMA Business School in the Netherlands.

Jürgen Schulze

Vice-Chairman and Member of the Operations Management Committee
VDGH - Sysmex

Dr. Jürgen Schulze became a board member of EDMA in 2003 and was elected as the Association's President in 2009. Beside his board position in MedTech Europe he is also on the board of the German National Association VDGH since 1997 and has been elected President from 2007 to 2009.

Dr. Schulze is the CEO and President of SYSMEX Europe, Middle East and Africa and an Executive Officer of SYSMEX CORP (Japan) after having held several other positions in SYSMEX since 1995. 
Prior to joining Sysmex, he has held several business functions in the IVD industry, mainly linked to Merck AG and Bayer Diagnostics, both in Europe and the USA.

Meinrad Lugan

Vice-Chairman and Member of the Operations Management Committee
BVMed – B Braun

Dr Meinrad Lugan has a university degree in chemistry (Dipl. Chem.), as well as a PhD in organic chemistry (Dr. rer. nat.), both from the University of Freiburg (Institute for Organic Chemistry and Biochemistry, Prof. Prinzbach).  He has held numerous positions including: Director of R & D  and Director of International Business Development  (BUCK System GmbH), Technical Director (BUCK Environmental LLC), Vice President (BUCK CMI Asia), and CEO (MCG Metall-Chemie Goerrig GmbH & Co KG).

Since 2000 he is Member of B. Braun Group Managing Board (Vorstand), Division OPM (Out Patient Market), and in 2004 also became Member of B. Braun Group Managing Board (Vorstand), Division HC (Hospital Market).
Since 2006 he is Member of the Board of BVMed (Bundesverband Medizintechnologie e. V., Berlin) and in 2007 he became Chairman of the Board. Also since 2006 he is Member of the Board of Eucomed.

Born in 1964, Dr Lugan is married with one son.

Christian Parry

Treasurer and Member of the Operations Management Committee
SIDIV - Stago

Christian Parry is Stago’s Senior Vice President, Public Affairs. Pharmacist specialised in medical biology per education, he worked in the Paris hospitals. Mr Parry started his career in the IVD industry over 30 years ago with experience in international marketing and sales, R&D, Production and General Management in the Stago and Sanofi groups. He is EDMA Vice President since 2010 and is also a Board member of MedTech Europe, SIDIV and ARIIS.

Peter Ellingworth

Board Member and Member of the Operations Management Committee

Peter hosts the industry Secretariat for the formal UK government engagement mechanism, the Ministerial Medical Technology Strategy Group (MMTSG), jointly chairs NHS England’s MedTech and Diagnostics Board and is a member of the Board of the Government’s HealthTech and Medicines Knowledge Transfer Network. He has also been involved in numerous roles to establish and lead England’s 15 Academic Health Science Networks which were formed in 2013, and in 2014 chaired the health economy workstream of the London Health Commission, set up by the city’s Mayor and Professor The Lord Darzi from Imperial College.

In 2013/14, he was the Chair of the Small Business Research Initiative (SBRI), connecting public sector challenges with solutions from industry, and thereby demonstrating the value of investing money from the NHS to support innovation by the MedTech sector. 

Peter has been elected as a Vice Chair of Eucomed, Board Member of MedTech Europe and leads MedTech Europe’s National Association Network.

Internationally, Peter is engaged with government on many levels to promote UK plc and assist companies to export. He is currently working on initiatives in this regard with the US State of Texas.

Peter has 35 years experience in sales, marketing and general management in the UK and across Europe and as a non-executive director of early stage companies.

Philippe Jacon

Board Member and Member of the Operations Management Committee

Philippe Jacon joined Cepheid as Executive Vice President International Commercial Operations in January 2013. In this role he leads the International growth strategy of the company, encompassing both our commercial sales and our HBDC program.

Priro to Cepheid, Philippe Jacon held the position of CEO of the Foundation for Innovative New Diagnostics (FIND) since October 2011. As such, he lead the strategy of this not-for-profit, Geneva-based International Organization to ensure it fulfills its mission to “Drive the development and early implementation of innovative diagnostic tests that have a high impact on patient care and disease control in low-resource settings”.

Philippe Jacon joined FIND from EDMA (European Diagnostic Manufacturers Association) where he acted as the Director General ad interim since March of 2011.

Prior to EDMA, he spent most of his career with BD (Becton Dickinson and Co) in various positions and locations.

Most notably, he was Worldwide President of BD Diagnostics-Diagnostic Systems and Worldwide President of BD Diagnostics - Microbiology Systems both positions based in Baltimore, MD; VP/GM Europe BD Medical - Diabetes Care. Prior to these roles, Mr. Jacon held positions of increasing responsibility in BD Medical-Pharmaceutical Systems in Europe and subsequently in the US where he was the VP/GM for the business. Mr. Jacon started his career at BD as a Sales Representative in France for BD Biosciences.

During his time in Baltimore, Mr. Jacon played an active role in the community. He served on the board of the University of Maryland BioPark and the Greater Baltimore Committee. He was also appointed by Governor Martin O’Malley to the Maryland Life Sciences Advisory Board.

Philippe Jacon has a Microbiologist Engineer degree from the Université de Bretagne Occidentale in France. He is a French citizen, married and has 3 children.

Paul Arnaoutis

Board Member – IVD
SEIV - Pavlos Arnaoutis S.A

Paul A.B. Arnaoutis specialised in Industrial Economics during his education at the Economic University of Piraeus. While studying, he worked in the family business, "ARNAOUTIS & Co. 'Ltd., a major supplier of Electrical Products, Medical equipment and Scientific Instruments to Public and Private Hospitals, Universities, Research Centers and Industries.

In the early 80s, he started his own personal business, which in 1986 was converted to a limited company, specialising in the marketing, import and distribution of medical diagnostics (IVD) and quality control products used also in pharmaceutical and food industries. He has attended numerouss sales and marketing seminars at the manufacturing plant of companies he distributed, as well as local and International conferences and workshops, on medical devices and in vitro diagnostics, external quality control and environmental analysis.

Since 2002, he is member of the Executive Committee of the Association of Health-Research & Biotechnology Industry, of which he is now the President. He has written several articles on health supplies which have been published in specialised magazines and in financial daily newspapers.

Ian Bell

Board Member – MD

Ian Bell is the Region President, Europe, Middle East and Africa at Alcon. As the second-largest region for Alcon, EMEA is comprised of more than 75 markets.

Mr. Bell brings more than 20 years of experience in the medical device and pharmaceutical industry. He joins Alcon from Hospira Inc. where, as Corporate Vice President and President of the EMEA region, he has successfully led its 500 million USD business since March 2015.

Prior to his work at Hospira Inc., Mr. Bell was Corporate Vice President and President of Allergan’s Asia Pacific region based in Singapore from 2008 to 2014. In that role, Mr. Bell transformed the business from less than 200 million USD to an over 500 million USD business in six years. Mr. Bell joined Allergan in 2005 as Vice President and Managing Director of its neurosciences division for Europe, Middle East and Africa.

Mr. Bell began his career at GlaxoSmithKline where he held roles of increasing responsibility and scope in sales, marketing and strategy for more than 10 years. Mr. Bell was awarded the degree of Bachelor of Arts with honors in economics from the University of York in the United Kingdom.


Paloma Beltran

Board Member – MD
FENIN - Boston Scientific Spain

Paloma Beltran's career in the healthcare technology sector began when she became marketing manager at St Jude Medical in 1997. Since then, all her management positions have always been at different stakeholders in the healthcare industry. 

After an extremely interesting period as development and sales manager at the health division of the Reuters group in Spain and Portugal, during which time she was able to meet and interact with health policy and economic decision makers in both countries and garner an in-depth understanding of institutions and managers at other companies, she decided to return to the medical device innovation and development sector of the industry. 

She has been responsible for Institutional Relations and Health Economics for the company Boston Scientific Ibérica S.A. in Spain since June 2005, and has also been Country Coordinator for the company in Spain since December 2012. Her multidisciplinary training, command of several languages and Master's Degrees in business management, hospital management and sales and communication management have all been helpful to her career.

Her work in the area of health economics has given her a thorough understanding of the technology, the law and of procedures for lobbying and introducing health systems, demonstrating cost effectiveness and the permanent added value of technology to healthcare professionals and decision-makers to help them to take the right decisions. This is the point of view which she endeavors to contribute to the stakeholders' board of directors, to put companies on a different track given the new context in which the industry must work.

Michelle Brennan

Board Member – MD
Johnson & Johnson Medical Device EMEA

Effective September 1, 2015  Michelle assumed the role of Company Group Chairmen,  Johnson & Johnson Medical Device Business in the EMEA region.

Michelle began her career at Johnson & Johnson as a sales representative for Janssen Pharmaceuticals in 1988.  Over the next 13 years, she advanced through positions of increasing responsibility in sales, marketing and management.

In 2000, Mrs. Brennan joined McNeil Consumer Healthcare as Executive Director, Pharmaceutical Marketing, advancing in 2001 to Vice President, Pharmaceutical Sales and Marketing and in 2005 she was appointed to General Manager of Ortho Women’s Health, McNeil Pediatrics and Patriot Pharmaceuticals.

In 2007, Mrs. Brennan joined Ethicon Endo-Surgery, part of the Johnson & Johnson Medical Device and Diagnostics Family of Companies as the Worldwide Vice President of Business Development and Strategy.

In 2009, she was appointed to Regional President of the Ethicon Endo-Surgery business in Europe, Middle East and Africa. 

In 2012, she was appointed the Worldwide President of the Energy Business Unit where she led a successful turnaround.

In 2014 she assumed the role of President, Enterprise Standards & Productivity to build Global Business Services for J&J.

Michelle earned a Bachelor of Science degree in business management from the University of Kansas.  In 1999, the YWCA of New Jersey honored her with its Women in Business Achievement award.

Brad Cannon

Board Member – MD
Smith & Nephew

Since March 1st 2016, Brad leads Smith & Nephew business in Europe and Canada.

Brad was most recently President of Global Orthopaedic Franchises, leading Smith & Nephew’s Reconstruction, Endoscopy, Trauma and Extremities businesses. He joined Smith & Nephew in 2012.

Prior to Smith & Nephew, Brad worked in Medtronic’s Spine and Biologics division.  From 2009 he was responsible for Spine’s International division and held positions heading U.S. sales and global commercial operations.

Brad is a graduate of Washington and Lee University, and the Wharton School of Business at the University of Pennsylvania.

John D. Coulter

Board Member– IVD
Abbott Diagnostics

John Coulter is Vice President, Diagnostics, Commercial Operations, Europe, Middle East and Africa. He was appointed to his current position May 2014. Previously, Mr. Coulter was Vice President, Molecular Diagnostics.

Mr. Coulter joined Abbott in 2000 and has served in various management positions for Abbott Diagnostics, including Divisional Vice President, U.S. Commercial Operations; Divisional Vice President, U.S. Sales; Divisional Vice President, Latin America and Canada; and General Manager, United Kingdom and Ireland.  He also served in marketing roles for Abbott’s global pharmaceuticals and nutrition businesses.

He earned a bachelor's degree in social sciences from Bishop’s University in Lennoxville, Canada.

Bill Doherty

Board Member – MD
IMDA - Cook Medical

Bill Doherty is Executive Vice President EMEA will Cook Medical and has more than 20 years experience in the MedTech industry. Prior to joining Cook Medical in 1994 as Managing Director of their Ireland facility, Bill held senior management positions with Atari, Digital Equipment Corporation and EG&G Electro-Optics.  Bill holds a B.Eng. (Electrical) degree from University College Dublin and an MBA from Trinity College Dublin.

Bill is a long-standing board member of the Irish Medical Device Association (IMDA) serving as chairman of the board in 2014. Bill also serves on the government appointed Expert Group on Future Skills Needs mandated to advise the Irish government on future skills needs in the Irish economy. Bill is a former director of the American Chamber of Commerce in Ireland and currently serves on the advisory board of the Materials and Surface Science Institute in the University of Limerick as well as on the advisory board of Limerick Institute of Technology.  

Lorenzo Fracassi

Board Member – IVD

Lorenzo Oreste Fracassi is Dasit’s Managing Director and represents the Italian Association, Assobiomedica. He has more than 10 years of experience in his current position.

Dasit is the largest Italian private family company in the IVD business in Italy and it is both a prominent manufacturer and distributor.

Ugo Gay

Board Member – IVD

Since 2000 he was appointed as a member of the executive committee in the Italian association of diagnostics (Assobiomedica) and since 2015 as Vice President in Assodiagnostica association. From 2006 to 2011 was part of the executive committee in the European in Vitro Diagnostic association (EDMA).

CURRENT PROFESSIONAL POSITION VP European Industrial Operations & Services

• 1995-1998: Commercial Director in Istituto Biologico Chemioterapico of Turin, a chemical-pharmaceutical company
• 1998-2000: CEO in a company of the Istituto Biologico Chemioterapico group
• 2000: He joined DiaSorin managing the merger with Byk Diagnostics (Altamo group) and up to his current position, he covered by the years the following professional positions:
 Country Manager Italy
 General Manager Spain & Portugal
 Regional Vice President Europe& Africa
 Vice President Industrial and Commercial Operations Italy and Uk Branch

Denis Hansjacob

Board Member – MD
SNITEM - St Jude

Denis Hansjacob joined St. Jude Medical in 1999 and is the General Manager of the French entity since 2004. In 2010, he became the Vice President for France, BeLux, Nordic & Central Europe. Before, he worked 11 years within ELA Medical assigned to various functions especially as General Manager ELA Germany. 

In France, Denis Hansjacob led the CRM working groups in SNITEM (industry association representing French medical device companies), before being elected on the Board of this Association. He is a Board Member of Eucomed.

Michael Heuer

Board Member – IVD
Roche Diagnostics Ltd.

Michael Heuer entered Roche Diagnostics Manneheim as Product Manager Immunoassays in 1983. Throughout his career with Roche, he has held different leading Marketing and Sales positions in Germany and the United States, before being appointed Head of the Roche Near Patient Testing Business Area in Austria in 2001. From 2004 to 2007, he was Head of the EMEA Subregion-1 covering Central and Eastern Europe, Turkey, Greece and South Africa. He currently heads the EMEA-LATAM Diagnostics Region (Europe, Middle East, Africa and Latin America) within Roche Diagnostics.

Eszter Kacskovics

Board Member – MD
SCA Hygiene Products AB

Work Experience in Health Care:
SCA Hygiene Products since 1998
-    Public Affairs/market Access positions in Region East/Europe since 2008
-    Commercial Director, leading the Hungarian organization 2005- 2008
-    Different controlling positions on local/regional level 1998 – 2005

Involvement in Trade association works:
From 2010 participation in Eucomed’s sector and working groups:
-    Community Care Sector group  ( CCG - active role since 2010)
-    Procurement group (since 2011, deep involvement in MEAT project in 2015)
-    Market Access & Economic Policies Network (since 2011 with active and less active periods )
-    Preliminary Board representative of CCG in Eucomed Board (from 06/2015)

2006 / 2010 Board Member in AMDM (Hungarian Industry Association, member of Eucomed)

Norbert Krysiuk

Board Member – IVD
IPDDL - Biomedica

In BIOMEDICA POLAND since 1999 Started as -Sales and Scientific Representative
Later - Product Management and Key Account - Sales Manager
Currently - Country Manager Vice president of the Board of BIOMEDICA Poland since 2005 
Member of the Board of Polish Diagnostic Manufacturers and Distributors Association IPDDL from 2013.
Biomedica Poland is a member of this IPDDL Association from 2002
Biomedica Group is International Distribution Company established and headquartered in Austria –Vienna in 1978. 
Polish Subsidiary since  1992.
Biomedica Group is distributor of Medical Devices , In vitro Diagnostic products and Clinical IT, Life Science and Vet and Food Diagnostic products, also is a manufacturer of Clinical “Biomedica Immunoassays”. Biomedica Group operates in eleven subsidiaries in Central Eastern Europe and Balkan area and currently employs 250 Professionals.


Katarzyna Mazur-Hofsaess

Board Member – MD
Zimmer Biomet

Katarzyna Mazur-Hofsaess was appointed President EMEA at Zimmer Biomet after the close of the merger in June 2015, having held this position since April 2013 at Zimmer. Dr. Mazur-Hofsaess joined Zimmer in February 2010 as Senior Vice President, EMEA Recon.
She has more than 20 years’ experience within the pharmaceutical, diagnostics and medical device sectors. Prior to joining Zimmer, Dr. Mazur-Hofsaess served in various management positions at Abbott Laboratories from 2001, most recently as Vice President, Diagnostics – Europe. She is a qualified Medical Doctor and also holds a Ph.D. from Gdansk Medical University, as well as an MBA from the Warsaw School of Economics and the University of Minnesota.

Gabriele Mazzoletti

Board Member – MD
Assobiomedica - Abbott

Gabriele Mazzoletti has 20 years of professional experience in Government Affairs in several companies of the healthcare sector, amongst them Baxter, Bristol Myers Squibb and most recently with Sorin Group where he was Director, Corporate Communications and Public Affairs. Since December, 2015, he is Director Global Government Affairs & Policy at Abbott Italy.
He holds a Master Degree in International Political Science from the Rome University.

Yasha Mitrotti

Board Member – IVD

Yasha MITROTTI, Colombian native and Italian by adoption, graduated as an industrial engineer from the university of the Andes in Bogotá (Colombia, 1996) after an academic curriculum in France, in the United States and in Colombia.

He joined bioMérieux in Colombia in 1997, where he held several commercial functions before being named Country Manager of the subsidiary in 2000. After spending 6 years in Colombia, he has been successively Country Manager in Brazil, Latin America Executive Director, Country Manager in Italy, Commercial Operations VP Europe and Corporate VP Europe Middle East Africa (EMEA).

Since July 2015, the scope of his missions also encompasses the Global Commercial Performance.


Benny Ons

Board Member – IVD

Benny Ons is Director Regulatory Affairs BD Diagnostics and BD Biosciences Europe. He is also chairman of the IVD Regulatory Affairs Committee and an Advisor to the AHWP TC. At the MedTech Europe board, he represents the Dutch Association, DIAGNED.

Markus Ott

Board Member – IVD
SVDI/ASID- Ascensia

Markus is currently the Global Head of Market Access, Policy  & Pricing, managing  Advocacy and Governmental Relationships for Ascensia Diabetes Care based in Basel, Switzerland. 

With more than nineteen years successful experience in international/global marketing & sales/commercialization/effectiveness, eBusiness, eDetailing, eProcurement,, strategic planning, project management, business development/strategy, mergers & acquisition and due diligence he has become a highly effective and creative leader with extensive knowledge of the healthcare industry. He has spent over 13 years working in the area of “International Market Access & Policy” for innovative medical technologies (Value Proposition, Healthcare Economics/Modeling/HTA,, Policy, Pricing & Reimbursement, Stakeholder Engagement & Advocacy, Government Relationship) with a track record in companies such as Johnson & Johnson, Abbott, Covidien and currently Ascensia.

Along with his corporate experience, he is also engaged with international association like AdvaMed, MedTech Europe / EDMA in various working groups (especially acting as a co-Chair of the HTA TF and chair of HTA Strategy and Policy Task Force at EDMA).

Further he is a current Executive Board Member of EDMA (European Diagnostic Manufacturers Association), SVDI/ASID (Swiss Diagnostic Association) and EPPOSI (European Platform for Patient's Organizations, Science & Industry)

In his «previous life» he founded and run an eBusiness company that he successfully handed over to a Pharma giant. Further he has been a CEOs of one of the globally leading electrical engineering/flood lightning company where he acted as  the president of the board of directors of this company.

Antonio La Regina

Board Member – MD

President of Europe, Middle East and Africa (EMEA) for ConvaTec, a global medical products and technologies company. Previous experience as Managing Director in both Italy and UKI and, most recently, as Vice President and General Manager for Western and Southern EMEA. Strong background in both Pharmaceutical and Medical Device Industry (Sales & Marketing, M&A, co-promotion, market access and new product launches in a variety of therapeutic areas). Degree in Biology (University of Milan – Italy), Ph.D in Pharmacology (Mario Negri Institutte of Pharmacological Research - Italy) and Master in General Management (CEDEP-INSEAD Business School in Fontainebleau – France). 



Jaume Serra

Board Member – IVD
FENIN - Werfen

Jaume Serra is Vice President, European Subsidiaries at Werfen, having been appointed to this position in 2011. Jaume is part of the Werfen Executive Board. Prior to this he had been General Manager of Werfen Italy since 2006.

In his previous experience Jaume had worked as a consultant for BCG in Mexico. Jaume studied Business Administration in Barcelona (1993) and then earned an MBA from IESE (2001) and an AMP from Insead (2014).

Stuart Silk

Board Member – MD

Working for Stryker since August 2008
Previous Stryker Experience: 
•    Managing Director, Southern Europe & Sr. Director Indirect Channels Europe
•    Joint Preservation Director Europe
•    Managing Director France
Previous Experience
•     Managing Director Southern Europe, Farnell Electronics
•     General Manager Brazil, Farnell Electronics
•     Bachelor of Arts, Management Studies, University of Leeds, UK
Personal Information:
•     Married: (Paula), 2 children
•     Languages: Portuguese, English, Spanish and French

Lene Garde Sommer

Board Member – MD
Novo Nordisk

Julia Stubben

Board Member – MD

Julia Stubben is the Vice President of Corporate Strategy of CVRx, a private med tech company that has developed the only implantable device for the treatment of heart failure and hypertension.  Julia had previously spent five years at Medtronic, where she helped the cardiac rhythm management group conceptualize and launch a disruptive business model, NayaMed, throughout Europe.  NayaMed was the first company to exclusively offer online distribution and support of implantable cardiac devices.  Prior to this, Julia held positions in business development at a private biotech company in Canada and in sales for Novartis Pharmaceuticals in the United States. Julia is a regular speaker on strategic innovation at the London Business School, and holds an MBA from INSEAD in France & Singapore and a Bachelors of Arts degree in Psychology from McGill University in Canada. 


Vicky Voulgaraki

Board Member – IVD
Thermo Fisher Scientific

Vicky Voulgaraki is Director for EU Government Affairs for Thermo Fisher Scientific. She joined the company's corporate team in 2010 and represents Thermo Fischer Scientific's businesses at the EU institutions and state governments. Vicky previously worked for the UK Permanent Representation to the EU, where she served as a political attaché in the Political and Institutional Affairs Unit and was instrumental in the activities of the UK Presidency of the Council of the European Union in 2005. She then joined Edelman, the world's largest public relations firm, as an Account Director, advising clients on food, environment, health, safety, tourism and intellectual property issues. For two years she seved as the Secretary General of the Toy Industries of Europe and orchestrated the industry's advocacy campaign on the revision of the Toy Safety Directive in Brussels and 12 Member States. Vicky is also the Vice Chair of the Innovation Task Force of the British Chamber of Commerce.

Kerstin Wagner

Board Member – IVD

Kerstin Wagner is General Manager Laboratory Diagnostics Central Europe, Russia, Middle East and Africa and represents Siemens Healthcare.  Kerstin has more than 20 years of experience in the IVD field. Throughout her career at Siemens and former Dade Behring she has held several leading positions in product line management, global marketing and global customer management before being appointed General Manager Laboratory Diagnostics on October 1, 2015.